These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9843186)
1. Venous thrombosis after extracorporeal shock-wave lithotripsy in a patient with heterozygous APC-resistance. Brodmann M; Ramschak H; Schreiber F; Stark G; Pabst E; Pilger E Thromb Haemost; 1998 Nov; 80(5):861. PubMed ID: 9843186 [No Abstract] [Full Text] [Related]
2. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers. Morange PE; Aillaud MF; Nicaud V; Henry M; Juhan-Vague I Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333 [No Abstract] [Full Text] [Related]
3. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis. Gessoni G; Valverde S Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946 [TBL] [Abstract][Full Text] [Related]
4. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden. Graf LL; Welsh CH; Qamar Z; Marlar RA Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697 [TBL] [Abstract][Full Text] [Related]
5. Risk of thrombosis with anomalies of the inferior vena cava and factor V Leiden. Sánchez Fernández GL; Reiss UM; de Alarcón PA Pediatr Blood Cancer; 2008 Mar; 50(3):731. PubMed ID: 17514740 [No Abstract] [Full Text] [Related]
6. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis. de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320 [TBL] [Abstract][Full Text] [Related]
7. [Multiple phlebothrombosis following cesarean section due to heterozygous factor V Leiden mutation detected post partum]. Grulich D; Schulze G; Riedel HH Zentralbl Gynakol; 1999; 121(11):526-9. PubMed ID: 10612220 [TBL] [Abstract][Full Text] [Related]
8. Haemorrhagic shock nine days after extracorporeal shock wave lithotripsy in a patient with haemophilia B. Lauper M; Lämmle B; Furlan M; Zehntner C; Zingg E Thromb Haemost; 1988 Dec; 60(3):532. PubMed ID: 3238660 [No Abstract] [Full Text] [Related]
9. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems. Girolami A; Simioni P; Tormene D Haematologica; 2000 Mar; 85(3):225-6. PubMed ID: 10702806 [No Abstract] [Full Text] [Related]
10. Diminished response to activated protein C is not correlated with severity of peripheral arterial occlusive disease. Köppel H; Renner W; Krippl P; Wascher TC; Pilger E Clin Lab; 2004; 50(11-12):689-93. PubMed ID: 15575311 [TBL] [Abstract][Full Text] [Related]
11. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population. Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913 [TBL] [Abstract][Full Text] [Related]
12. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation. De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766 [TBL] [Abstract][Full Text] [Related]
13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
14. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075 [TBL] [Abstract][Full Text] [Related]
15. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C. Luddington R; Jackson A; Pannerselvam S; Brown K; Baglin T Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373 [TBL] [Abstract][Full Text] [Related]
16. [Superficial venous thrombosis of the lower limbs: prospective analysis in 100 patients]. Gillet JL; Perrin M; Cayman R J Mal Vasc; 2001 Feb; 26(1):16-22. PubMed ID: 11240525 [TBL] [Abstract][Full Text] [Related]
17. Activated protein C resistance in anterior ischaemic optic neuropathy. Nagy V; Facsko A; Takacs L; Balazs E; Berta A; Balogh I; Edes I; Czuriga I; Pfliegler G Acta Ophthalmol Scand; 2004 Apr; 82(2):140-3. PubMed ID: 15043529 [TBL] [Abstract][Full Text] [Related]
18. In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity. Santacroce R; Bossone A; Brancaccio V; Fortina P; Margaglione M Thromb Haemost; 2000 Jun; 83(6):963-4. PubMed ID: 10896257 [No Abstract] [Full Text] [Related]
19. [Prevention of thrombosis in genetic susceptibility? Thrombosis ABC: APC resistance]. Stiefelhagen P MMW Fortschr Med; 1999 Sep; 141(35):44. PubMed ID: 10897957 [No Abstract] [Full Text] [Related]
20. Cerebral venous thrombosis associated to homozygous factor V Leiden mutation in a female of Syrian origin. Mira Y; Alfaro A; Estellés A; Vayá A; Ferrando F; Villa P Haematologica; 2002 Jan; 87(1):ELT02. PubMed ID: 11801486 [No Abstract] [Full Text] [Related] [Next] [New Search]